Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients

Respiratory Care

Volumn 50, Issue 10, 2005, Pages 1331-1344

  Dhand, Rajiv ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aerosol; Bronchodilator; Corticosteroids; Drug delivery; Dry powder inhaler; Endotracheal tube; Mechanical ventilation; Metered dose inhaler

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; FENOTEROL; FENOTEROL PLUS IPRATROPIUM BROMIDE; FLAVORING AGENT; FLUNISOLIDE; FLUORINATED HYDROCARBON; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; ISOETARINE; ISOPRENALINE; LEVALBUTEROL; ORCIPRENALINE; PRESERVATIVE; PROPELLANT; SALBUTAMOL; SALBUTAMOL SULFATE; SURFACTANT;

AEROSOL; AIRFLOW; ARTIFICIAL VENTILATION; ASTHMA; BRONCHODILATATION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DENSITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG EXCRETION; DRUG INDICATION; DRUG MEGADOSE; DRUG RESPONSE; DRY POWDER; ENDOTRACHEAL TUBE; GAMMA SCINTIGRAPHY; GAS; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEAT; HUMAN; HUMIDITY; HYPOKALEMIA; IN VITRO STUDY; IN VIVO STUDY; LUNG DEPOSIT; METERED DOSE INHALER; NEBULIZER; PARTICLE SIZE; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; POWDER INHALER; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SINGLE DRUG DOSE; VAPOR PRESSURE; VENTILATOR; INHALATIONAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; HUMANS; IPRATROPIUM; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY THERAPY;

EID: 33644657078     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (91)

1. Dolovich M. Changing delivery methods for obstructive lung diseases. Curr Opin Pulm Med 1997;3(3):177-189.
2. Fink JB, Dhand R. Laboratory evaluation of metered-dose inhalers with models that simulate interaction with the patient. Respir Care Clin North Am 2001;7(2):303-317.
3. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in-vitro and in-vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation, and defining efficiency enhancing factors. Am J Respir Crit Care Med 1999;159(1): 63-68.
4. Everard ML, Devadason SG, Le Souef PN. In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system. Thorax 1996;51(1):75-77.
5. Iacono AT, Smaldone GC, Keenan RJ, Diot P, Dauber JH, Zeevi A, et al. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med 1997;155(5):1690-1698.
6. Davies RJ, Stampone P, O'Connor BJ. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir Med 1998;92 Suppl A:23-31.
7. Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J. Hydrofluoroalkane- 134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma. Chest 1999;115(2):343-351.
8. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003; 56(6):600-612.
9. Dhand R, Fink J. Dry powder inhalers. Respir Care 1999;44(8):940-951.
10. Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC, Migounov VA. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study. Respir Care 2003;48(11):1025-1032.
11. Jashnani RN, Byron PR, Dalby RN. Testing of dry powder aerosol formulations in different environmental conditions. Int J Pharm 1995; 113:123-130.
12. Lindsay DA, Russell NL, Thompson JE, Warnock TH, Shellshear ID, Buchanan PR. A multicenter comparison of the efficacy of terbutaline Turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. Eur Respir J 1994;7(2):342-345.
13. Moren F. Aerosol dosage forms and formulations. In: Moren F, Dolovich MB, Newhouse MT, Newman SP, editors. Aerosols in Medicine, 2nd ed. Amsterdam: Elsevier; 1993:321-350.
14. O'Callaghan C, Wright P. The metered-dose inhaler. In: Bisgaard H, O'Callaghan C, Smaldone GC. Drug delivery to the lung. New York: Marcel Dekker; 2002:337-370.
15. Ross DL, Gabrio BJ. Advances in metered-dose inhaler technology with the development of chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999;12(3):151-160.
16. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci 1969;58(4):484-486.
17. Kim CS, Trujillo D, Sackner MA. Size aspects of metered-dose inhalers. Am Rev Respir Dis 1985;132(1):137-142.
18. Dolovich M. Measurement of particle size characteristics of metered-dose inhaler (MDI) aerosols. J Aerosol Med 1991;4(3):251-264.
19. Dhand R. Basic techniques in aerosol delivery during mechanical ventilation. Respir Care 2004;49(6):611-622.
20. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically- ventilated patients. Am J Respir Crit Care Med 1997;156(1):3-10.
21. Rau JL, Dunlevy CL, Hill RL. A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically-ventilated lung model. Respir Care 1998;43(9):705-712.
22. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with the CFC-beclomethasone. Eur Respir J 1998;12(6):1346-1353.
23. Duarte AG, Momii K, Bidani A. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically-ventilated patients: comparison of magnitude and duration of response. Respir Care 2000;45(7):817-823.
24. Bishop MJ, Larson RP, Buschman DL. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology 1990;73(6):1263-1265.
25. Rau JL, Harwood RJ, Groff JL. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an in vitro study. Chest 1992;102(3):924-930.
26. Fuller HD, Dolovich MB, Turpie FH, Newhouse MT. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients: a study comparing four different actuator devices. Chest 1994;105(1):214-218.
27. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995;152(4 Pt 1): 1391-1394.
28. Dhand R, Duarte AG, Jubran A, Jenne JW, Fink JB, Fahey PJ, Tobin MJ. Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1996;154(2 Pt 1):388-393.
29. Dhand R. Maximizing aerosol delivery during mechanical ventilation: go with the flow and go slow. Intensive Care Med 2003;29(7): 1041-1042.
30. Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Deposition of aerosol from metered-dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med 1996;154(2 Pt 1):382-387.
31. Hess DR, Dillman C, Kacmarek RM. In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressure control versus volume control ventilation. Intensive Care Med 2003; 29(7):1145-1150.
32. Fuller HD, Dolovich MB, Chambers C, Newhouse MT. Aerosol delivery during mechanical ventilation: a predictive in vitro lung model. J Aerosol Med 1992;5:251-259.
33. Lange CF, Finlay WH. Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med 2000;161(5):1614-1618.
34. Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or helium/oxygen mixture. Exp Lung Res 1989;15(4):575-585.
35. Habib DM, Garner SS, Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 1999;19(2):143-149.
36. Goode ML, Fink JB, Dhand R, Tobin MJ. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001;163(1):109-114.
37. Crogan SJ, Bishop MJ. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 1989;70(6):1008-1010.
38. Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatric Pulmonol 1986;2(1):19-26.
39. O'Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992;145(5): 1117-1122.
40. Dhand R. Special problems in aerosol delivery: artificial airways. Respir Care 2000;45(6):636-645.
41. Taylor RH, Lerman J, Chambers C, Dolovich M. Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest 1993;103(3):920-924.
42. Spahr-Schopfer IA, Lerman J, Cutz E, Newhouse MT, Dolovich M. Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Crit Care Med 1994;150(3):790-794.
43. Ebert J, Adams AB, Green-Eide B. An evaluation of MDI (metered dose inhaler) spacers and adapters: their effect on the respirable volume of medication. Respir Care 1992;37(8):862-868.
44. Niven RW, Kacmarek RM, Brain JD, Peterfreund RA. Small bore nozzle extensions to improve the delivery efficiency of drugs from metered-dose inhalers: laboratory evaluation. Am Rev Respir Dis 1993;147(6Pt 1):1590-1594.
45. Moren F, Andersson J. Fraction of dose exhaled after administration of pressurized inhalation aerosols. Int J Pharm 1980;6:295-300.
46. Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981;36(1):52-55.
47. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered-dose inhalers. Chest 1981;80(6 Suppl): 911-915.
48. Duarte AG, Dhand R, Reid R, Fink JB, Fahey PJ, Tobin MJ, Jenne JW. Serum albuterol levels after metered-dose inhaler administration to ventilated patients and healthy controls. Am J Respir Crit Care Med 1996;154(6 Pt 1):1658-1663.
49. Marik P, Hogan J, Krikorian J. A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients. Chest 1999;115(6):1653-1657.
50. Boucher BA, Kuhl DA, Coffey BC, Fabian TC. Drug use in a trauma intensive-care unit. Am J Hosp Pharm 1990;47(4):805-810.
51. Ballard J, Lugo RA, Salyer JW. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Respir Care 2002;47(1):31-38.
52. Gold MI. Treatment of bronchospasm during anesthesia. Anesth Analg 975;54(6):783-786.
53. Gay PC, Rodarte JR, Tayyab M, Hubmayr RD. Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am Rev Respir Dis 1987;136(4):880-885.
54. Fernandez A, Lazaro A, Garcia A, Aragon C, Cerda E. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am Rev Respir Dis 1990;141(1):164-168.
55. Gay PC, Patel HG, Nelson SB, Hubmayr RD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991;99(1):66-71.
56. Mancebo J, Amaro P, Lorino H, Lemaire F, Harf A, Brochard L. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 1991;144(1):95-100.
57. Dhand R, Jubran A, Tobin MJ. Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1995;151(6):1827-1833.
58. Manthous CA, Chatila W, Schmidt GA, Hall JB. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest 1995;107(1):210-213.
59. Torres A, Anders M, Heulitt MJ, Anderson P. Efficacy of metered-dose inhaler administration of albuterol in intubated infants. Chest 1997;112(2):484-90.
60. Waugh JB, Jones DF, Aranson R, Honig EG. Bronchodilator response with use of Optivent versus Aerosol Cloud Enhancer metered-does inhaler spacers in patients receiving mechanical ventilation. Heart-Lung 1998;27(6):418-23.
61. Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Eur Respir J 1998;12(1):165-169.
62. Guerin C, Chevre A, Dessirier P, Poncet T, Becquemin MH, Dequin PF, et al. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159(4 Pt 1):1036-1042.
63. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Intensive Care Med 1999;25(11):1215-1221.
64. Sivakumar D, Bosque E, Goldman SL. Bronchodilator delivered by metered-dose inhaler and spacer improves respiratory system compliance more than nebulizer-delivered bronchodilator in ventilated premature infants. Pediatr Pulmonol 1999;27(3):208-212.
65. Mouloudi E, Prinianakis G, Kondili E, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern. Eur Respir J 2000;16(2):263-268.
66. Mouloudi E, Maliotakis C, Kondili E, Kafetzakis A, Georgopoulos D. Duration of salbutamol-induced bronchodilation delivered by metered-dose inhaler in mechanically ventilated COPD patients. Monaldi Arch Chest Dis 2001;56(3):189-194.
67. Wegener T, Wretman S, Sandhagen B, Nystrom SO. Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment. Acta Anesthesiol Scand 1987;31(7):652-654.
68. Yang SC, Yang SP, Lee TS. Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis. Chest 1994; 105(5):1511-1515.
69. Fresoli RP, Smith RM Jr, Young JA, Gottshall SC. Use of aerosol isoproterenol in an anesthesia circuit. Anesth Analg 1968;47(2):127-132.
70. Sprague DH. Treatment of intraoperative bronchospasm with nebulized isoetharine. Anesthesiology 1977;46(3):222-224.
71. Fernandez A, Munoz J, de la Calle B, Alia I, Ezpeleta A, de la Cal MA, Reyes A. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med 1994;20(3):199-202.
72. Corbridge T, Hall JB. Pharmacotherapy of status asthmaticus. In: Leff AR, editor. Pulmonary and critical care pharmacology and theapeutics. New York: McGraw Hill; 1996:773-781.
73. Bates JH, Rossi A, Milic-Emili J. Analysis of the behaviour of the respiratory system with constant inspiratory flow. J Appl Physiol 1985;58(6):1840-1848.
74. Bates JH, Milic-Emili J. The flow interruption technique for measuring respiratory resistance. J Crit Care 1991;6(4):227-238.
75. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction. Am Rev Respir Dis 1982;126(1):166-170.
76. Higgins RM, Cookson WO, Lane DJ, John SM, McCarthy GL, McCarthy ST. Cardiac arrhythmias caused by nebulized beta-agonist therapy. Lancet 1987;2(8563):863-864.
77. Kung M, Croley SW, Phillips BA. Systemic cardiovascular and metabolic effects associated with inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 1987;91(3): 382-387.
78. Breeden CC, Safirstein BH. Albuterol and spacer-induced atrial fibrillation. Chest 1990;98(3):762-763.
79. Newhouse MT, Chapman KR, McCallum AL, Abboud RT, Bowie DM, Hodder RV, et al. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest 1996; 110(3):595-603.
80. Silverglade A. Cardiac toxicity of aerosol propellants. JAMA 1972; 222(7):872-879.
81. Dollery CT, Williams FM, Draffan GH, Wise G, Sahyoun H, Paterson GW, Walker SR. Arterial blood levels of fluorocarbons in asthmatic patients. Clin Pharmacol Ther 1974;15(1):59-66.
82. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001;163(2):540-577.
83. Bott J, Carroll MP, Conway JH, Keilty SE, Ward EM, Brown AM, et al. Randomized controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993;341(8860):1555-1557.
84. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333(13):817-822.
85. Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995;151(6):1799-1806.
86. Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003;326(7382):185-189.
87. Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997;52(2):171-175.
88. Chatmongkolchart S, Schettino GP, Dillman C, Kacmarek RM, Hess DR. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med 2003;30(11):2515-2519.
89. Fauroux B, Itti E, Pigeot J, Isabey D, Meignan M, Ferry G, et al. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med 2000;162(6):2265-2271.
90. Pollack CV Jr, Fleisch KB, Dowsey K. Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med 1995;26(5): 552-557.
91. Nava S, Karakurt S, Rampulla C, Braschi A, Fanfulla F. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized controlled study. Intensive Care Med 2001;27(10):1627-1635.